We are live on ! Find out more
OYST

Oyster Point Pharma, Inc. Common Stock
OYST

Delisted

OYST was delisted on the 30th of December, 2022.

Back to rankings

1 hedge funds and large institutions have $11 invested in Oyster Point Pharma, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $11 → $11 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$11 – – –

OYST Hedge Fund Activity: Q3 2023 in Review

1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Oyster Point Pharma, Inc. Common Stock (OYST) for Q3 2023, worth a combined $11 — unchanged from a quarter earlier.

Fund positioning in OYST was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Oyster Point Pharma, Inc. Common Stock (OYST) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $11 of Oyster Point Pharma, Inc. Common Stock stock for Q3 2023, unchanged quarter-over-quarter.
  • 0 funds opened new Oyster Point Pharma, Inc. Common Stock positions in Q3 2023 and 0 closed out.

Based on aggregated 13F filings for Q3 2023.